On November 7, 2022, the board of directors of OraSure Technologies, Inc. appointed Kathleen G. Weber, the company's current President of Molecular Solutions, as the company's Chief Product Officer, effective November 14, 2022. In connection with the appointment of Ms. Weber as the company's Chief Product Officer, on November 7, 2022, the Company and Ms. Weber entered into Amendment No. 2 to that certain Employment Agreement, dated as of January 1, 2019, by and between the Company, DNA Genotek Inc., the Company's wholly-owned subsidiary, and Ms. Weber.

The amendment reflects the change in Ms. Webers title and duties and makes certain changes to the Employment Agreements definition of Good Reason. Upon a resignation from employment by Ms. Weber for Good Reason, Ms. Weber would be entitled to severance benefits as set forth in the Employment Agreement, which severance benefits were not changed by the amendment. Lisa Nibauer has chosen to resign as the company's President of Diagnostics, effective November 11, 2022.